Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies

Biomed Pharmacother. 2018 Oct:106:1082-1090. doi: 10.1016/j.biopha.2018.07.056. Epub 2018 Jul 17.

Abstract

The search for new drugs for the treatment of leishmaniasis is an important strategy for improving the current therapeutic arsenal for the disease. There are several limitations to the available drugs including high toxicity, low efficacy, prolonged parenteral administration, and high costs. Steroids are a diverse group of compounds with various applications in pharmacology. However, the antileishmanial activity of this class of molecules has not yet been explored. Therefore, in the present study, we investigated the antileishmanial activity and cytotoxicity of novel steroids against murine macrophages with a focus on the derivatives of cholesterol (CD), cholic acid (CA), and deoxycholic acid (DA). Furthermore, the mechanism of action of the best compound was assessed, and in silico studies to evaluate the physicochemical and pharmacokinetic properties were also conducted. Among the sixteen derivatives, schiffbase2, CD2 and deoxycholic acid derivatives (DOCADs) were effective against promastigotes of Leishmania species. Despite their low toxicity to macrophages, the majority of DOCADs were active against intracellular amastigotes of L. amazonensis, and DOCAD5 exhibited the best biological effect against these parasitic stages (IC50 = 15.34 μM). Neither the CA derivatives (CAD) nor DA alone inhibited the intracellular parasites. Thus, the absence of hydroxyl in the C-7 position of the steroid nucleus, as well as the modification of the acid group in DOCADs were considered important for antileishmanial activity. The treatment of L. amazonensis promastigote forms with DOCAD5 induced biochemical changes such as depolarization of the mitochondrial membrane potential, increased ROS production and cell cycle arrest. No alterations in parasite plasma membrane integrity were observed. In silico physicochemical and pharmacokinetic studies suggest that DOCAD5 could be a good candidate for an oral drug. The data demonstrate the potential antileishmanial effect of certain steroid derivatives and encourage new in vivo studies.

Keywords: Antileishmanial activity; Apoptosis; Cholesterol; Colic acid; Deoxycholic acid; Leishmaniasis; Steroids.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Animals
  • Cell Cycle Checkpoints / drug effects
  • Cholesterol / analogs & derivatives
  • Cholesterol / chemical synthesis
  • Cholesterol / pharmacokinetics
  • Cholesterol / pharmacology*
  • Cholic Acid / chemical synthesis
  • Cholic Acid / pharmacokinetics
  • Cholic Acid / pharmacology
  • Deoxycholic Acid / analogs & derivatives
  • Deoxycholic Acid / chemical synthesis
  • Deoxycholic Acid / pharmacokinetics
  • Deoxycholic Acid / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Discovery / methods*
  • Leishmania / drug effects*
  • Leishmania / growth & development
  • Leishmania / metabolism
  • Leishmaniasis / drug therapy*
  • Leishmaniasis / parasitology
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / parasitology
  • Membrane Potential, Mitochondrial / drug effects
  • Mice, Inbred BALB C
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Models, Biological
  • Molecular Structure
  • Oxidative Stress / drug effects
  • Parasitic Sensitivity Tests
  • Structure-Activity Relationship
  • Trypanocidal Agents / chemical synthesis
  • Trypanocidal Agents / pharmacokinetics
  • Trypanocidal Agents / pharmacology*

Substances

  • Trypanocidal Agents
  • Deoxycholic Acid
  • Cholesterol
  • Cholic Acid